Acquired Factor V Inhibitor Presenting as a Spontaneous Intramuscular Haematoma in a 95-Year-Old Man With Evidence of Immune Dysregulation: A Case Report
Year: 2026
Type: article
Abstract: Acquired factor V deficiency (AFVD) is a rare, acquired bleeding disorder caused by the development of inhibitors against coagulation factor V. It most commonly occurs following exposure to bovine thrombin, surgery, infections, antibiotics, autoimmune disease or malignancy, although a proportion of cases remain idiopathic. Clinical presentation is variable and ranges from incidental coagulation abnormalities to life-threatening haemorrhage. Owing to its rarity, diagnosis requires a high index of suspicion. This case presents a 95-year-old man who came in with acute left thigh pain and swelling without preceding trauma. Imaging demonstrated a large spontaneous intramuscular haematoma involving the anterior compartment of the thigh with evidence of active contrast extravasation. Laboratory investigations showed marked prolongation of both the prothrombin time (PT) and activated partial thromboplastin time (APTT). Mixing studies demonstrated incomplete correction, and coagulation factor assays identified isolated severe factor V deficiency (5 IU/dL). Finding a factor V inhibitor titre of 0.8 Bethesda units (BU) was strongly suggestive of an acquired inhibitor. Further investigations demonstrated a positive direct antiglobulin test (DAT) (IgG 3+), positive lupus anticoagulant and polyclonal hypergammaglobulinemia, although extensive autoimmune and malignancy screening was otherwise unremarkable. He was managed conservatively with fresh frozen plasma (FFP), tranexamic acid, corticosteroids and intravenous immunoglobulin (IVIG). The haematoma showed clinical improvement without further documented expansion; however, coagulation parameters fluctuated and remained markedly prolonged at the final assessment. Repeat factor V activity and inhibitor titres were unavailable, so inhibitor eradication could not be confirmed. His admission was subsequently complicated by hospital-acquired pneumonia and SARS-CoV-2 infection, resulting in progressive respiratory failure and death.
Source: Cureus
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7237364377
